Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia

Zhiqian Tong1, Jinling Zhang, Wenhong Luo

  • 1State Key Lab of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Neurobiology of Aging
|November 3, 2009
PubMed

Insights

Elevated endogenous formaldehyde in urine correlates with senile dementia and lower cognitive scores. This finding suggests urine formaldehyde may serve as a non-invasive biomarker for dementia diagnosis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Exogenous formaldehyde exposure is known to impair cognition and memory.
  • Recent studies link pathological formaldehyde levels to amyloid-beta (Aβ) deposition and tau protein misfolding.
  • Endogenous formaldehyde is proposed as a potential biomarker for progressive senile dementia.

Purpose of the Study:

  • To investigate the correlation between endogenous formaldehyde levels in urine and cognitive function in senile dementia patients.
  • To assess the relationship between urine formaldehyde levels and Mini-Mental State Examination (MMSE) scores.
  • To explore the role of endogenous formaldehyde in Alzheimer's disease (AD) and aging-related cognitive decline.

Main Methods:

  • High-performance liquid chromatography with fluorescence detection was used to analyze formaldehyde levels in human urine samples.
  • Urine samples were collected from dementia patients, individuals with mild cognitive impairment, hypertension, diabetes, and healthy controls.
  • Formaldehyde levels were also measured in autopsy hippocampus samples from AD patients and brains of AD animal models (SAMP8, APP-transgenic, APP/PS1-transgenic mice).

Main Results:

  • Significantly elevated urine formaldehyde levels were observed in dementia patients and mildly elevated levels in those with mild cognitive impairment.
  • Urine formaldehyde levels showed a significant inverse correlation with MMSE scores (Rs=-0.441, p<0.0001).
  • Increased formaldehyde levels were found in the hippocampus of AD patients and in the brains of aging and AD-like transgenic mice, correlating with Aβ deposition and memory loss.

Conclusions:

  • Cognitive impairments in senile dementia are likely associated with endogenous formaldehyde levels.
  • Urine formaldehyde levels may serve as a non-invasive method for the investigation and diagnosis of senile dementia.
  • Endogenous formaldehyde is implicated in aging-related cognitive decline and Alzheimer's disease pathogenesis.

Related Concept Videos

Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...